Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Carotid artery disease, Epistaxis
Clinical narrative: Nosebleed; Vascular Carotid Surgery; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient received BNT162b2 (BNT162B2), on 01Jul2021 as dose 2, single (Lot number: EW0217) at the age of 71 years for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing). Concomitant medication(s) included: CLOPIDOGREL, start date: 2021 (ongoing); LISINOPRIL taken for hypertension, start date: 2021 (ongoing); LASIX [FUROSEMIDE], start date: 2021 (ongoing); LIPITOR, start date: 2021 (ongoing); ASPIRIN 81, start date: 2021 (ongoing). Vaccination history included: BNT162b2 (Dose Number: 1, Lot Number: EW0191), administration date: 07Jun2021, when the patient was 71-year-old, for Covid-19 Immunization. The following information was reported: CAROTID ARTERY DISEASE (medically significant) with onset Nov2021, outcome "unknown", described as "Vascular Carotid Surgery"; EPISTAXIS (non-serious), outcome "unknown", described as "Nosebleed". The events "vascular carotid surgery" and "nosebleed" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of carotid artery disease, epistaxis.  Clinical course: Caller was a consumer was calling about the Pfizer Covid 19 Vaccine. The caller received the first, second, and booster doses of the vaccine. After the second dose and the booster dose the caller had nosebleeds. Caller was asking for information related to the vaccine and blood thinners. Caller stated that these occurred after her second dose and booster dose of the vaccine. Stated that it wasn't severe. She would feel something in her nose and then when she would blow it there would be blood. Caller stated that she took Vitamin C, so she increased her Vitamin C at that time and the nosebleed went away after several days. Caller stated that the nosebleed was more after the second dose of the vaccine than the booster dose of the vaccine. Caller stated that she was going to call sooner. When she realized she will probably need a second booster she thought she would call and ask about this. She was somewhat surprised that it happened with her booster dose. Caller stated that she was on several medications. Initially stated that her question was related to Lipitor, which she stated she thought was a blood thinner. Caller then corrected herself, stated the blood thinner she was thinking of was Plavix, Clopidogrel; not Lipitor. Caller stated that her Clopidogrel was in a pharmacy vial. Caller mentioned that she was on Lipitor. Stated that she was thinking Lipitor was an Aspirin, then said no, maybe its a Calcium. Caller provided no further information related to her Lipitor. Additional Vaccines Administered on Same Date of the Pfizer Suspect was reported as none. Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was reported as none. Relevant tests were reported as none.